VANI VANI
Company Profile ↓Company Overview
VANI (VANI) is a publicly traded company listed on with a market capitalization of $105.47M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | +3.76% |
| 6 Months: | -1.43% |
| 3 Months: | +10.40% |
| 1 Month: | +2.22% |
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)54.73 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 26.2% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | 1.05K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 691.00K | 141.00K | -2.20M | -1.44M | -2.59M | -118.00K | -1.11M | 609.00K | 1.25M | 308.00K | 1.07M | 462.00K | 167.00K | 397.00K | 349.00K | 108.00K | 373.00K | - | 0 | - | 500.00K | - | 0 | - | 130.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.56M | 7.46M | 6.72M | 6.81M | 6.82M |
| Operating Income | -5.48M | -5.82M | -8.51M | -8.50M | -10.38M | -7.55M | -6.87M | -6.75M | -7.43M | -9.77M | -7.99M | -8.55M | -8.88M | -9.77M | -8.44M | -7.62M | -8.13M | -8.90M | -3.12M | -1.60M | -1.27M | -2.84M | -2.30M | -3.48M | -1.29M | -3.91M | -4.09M | -5.44M | -6.60M | -7.00M | -7.14M | -6.23M | -5.68M | -6.31M | - | -6.56M | -7.46M | -6.72M | -6.81M | -6.82M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -6.46M | -7.36M | -6.62M | -6.70M | -6.69M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -6.30M | -7.14M | -6.53M | -6.63M | -6.78M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income | -5.47M | -5.82M | -8.50M | -8.49M | -10.37M | -7.55M | -6.84M | -6.72M | -7.41M | -9.75M | -7.96M | -8.52M | -8.86M | -9.70M | -8.44M | -7.58M | -7.87M | -8.89M | -3.10M | -1.60M | -1.29M | -2.99M | -2.67M | -3.49M | -1.28M | -3.92M | -4.10M | 1.42M | -6.32M | -6.53M | -6.78M | -6.04M | -5.36M | -6.04M | - | -6.30M | -7.14M | -6.53M | -6.63M | -6.78M |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.10 | - | - | - | 0.04 | - | -0.13 | -0.13 | -0.12 | -0.10 | -0.11 | -0.11 | -0.11 | -0.12 | -0.11 | - | -0.08 |
| R&D Expense | - | 762.00K | 916.00K | 1.59M | - | 1.85M | 1.95M | 1.83M | - | 2.47M | 2.42M | 2.67M | - | 2.18M | 3.44M | 3.38M | - | 3.89M | 323.00K | 279.00K | - | 334.00K | 695.00K | 2.87M | - | 2.68M | 3.20M | 3.86M | 3.96M | 3.86M | 4.44M | 3.73M | 3.51M | 4.20M | - | 4.22M | 4.76M | 4.52M | - | 4.39M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.56M | 3.40M | 8.90M | 4.00M | 7.96M | 6.90M | 3.38M | - | - | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -4.06M | -160.00K | 3.66M | -6.09M | 2.85M | 2.01M | 1.23M | 500.00K | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - | - | - | - | 21.24M | 26.96M | 24.68M | 27.56M |
| Operating Income | -18.00M | -21.23M | -20.05M | -33.21M | -28.61M | -35.18M | -33.95M | -14.90M | - | -21.24M | -26.96M | -24.68M | -27.56M |
| EBITDA | - | - | - | - | - | - | - | - | - | -20.86M | -26.61M | -24.28M | -27.13M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | -13.89M | -25.65M | -23.49M | -26.61M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income | -22.97M | -35.20M | -20.02M | -33.18M | -28.52M | -35.09M | -33.59M | -14.88M | - | -13.89M | -25.65M | -23.49M | -26.61M |
| Diluted EPS | - | - | - | - | - | - | - | - | - | -0.36 | -0.50 | -0.43 | -0.43 |
| R&D Expense | 3.25M | 5.04M | 3.04M | 5.35M | 7.89M | 10.01M | 13.14M | 4.84M | 11.00M | 14.17M | 16.97M | 15.74M | 18.13M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 43.07M | 28.25M | 16.81M | 14.50M | 10.68M | 16.60M | 4.46M | - | 51.13M | 45.80M | 41.56M | 39.39M |
| Current Assets | - | - | - | - | - | - | - | - | - | - | 47.53M | 23.06M | 20.44M | 17.90M |
| Cash & Equivalents | 145.00K | 62.00K | 619.00K | 15.96M | 10.88M | 7.84M | 4.47M | 11.33M | 3.18M | - | 45.08M | 20.65M | 18.35M | 16.23M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | 0 | 253.00K | 654.00K |
| Total Liabilities | - | - | - | - | - | - | 7.60M | 9.32M | 5.13M | - | 6.82M | 25.04M | 23.95M | 23.66M |
| Current Liabilities | - | - | 8.45M | 7.98M | 5.66M | 6.62M | 7.60M | 6.96M | 5.13M | - | 6.82M | 5.72M | 5.99M | 6.60M |
| Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Debt | - | - | - | - | - | - | - | - | - | - | 955.00K | 20.70M | 19.31M | 18.86M |
| Total Equity | -3.04M | -9.22M | 34.62M | 20.26M | 11.15M | 7.88M | 3.08M | 7.28M | 1.95M | - | 44.31M | 20.76M | 17.61M | 15.73M |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | 50.74M | 51.03M | 59.23M | 76.43M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | -20.55M | -25.07M | -23.95M | -29.81M | -27.63M | -16.82M | - | -18.79M | -23.70M | -20.79M | -24.32M |
| Investing Cash Flow | -4.55M | -25.95M | 17.52M | -490.00K | -265.00K | -163.00K | -493.00K | 68.00K | - | -338.00K | -887.00K | -556.00K | -1.17M |
| Financing Cash Flow | 21.97M | 43.80M | 2.76M | 20.45M | 21.17M | 26.60M | 34.99M | 8.60M | - | 63.39M | 133.00K | 19.05M | 23.27M |
| Capital Expenditure | -246.00K | -560.00K | -762.00K | -490.00K | -265.00K | -163.00K | -493.00K | -330.00K | - | -338.00K | -887.00K | -556.00K | -1.17M |
| Free Cash Flow | - | - | -21.31M | -25.56M | -24.21M | -29.97M | -28.12M | -17.15M | - | -19.12M | -24.59M | -21.34M | -25.49M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | 44.27M | -24.45M | -2.29M | -2.22M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | -259.7% | -4.7% | 41.1% | -152.3% | 35.7% | 29.1% | 36.3% | - | - | - | - | - | - |
| Operating Margin % | -1,150.0% | -624.5% | -225.2% | -830.2% | -359.2% | -510.2% | -1,004.9% | - | - | - | - | - | - |
| Net Margin % | -1,467.7% | -1,035.3% | -224.9% | -829.5% | -358.1% | -508.9% | -994.1% | - | - | - | - | - | - |
| ROE % | 249.1% | -101.7% | -98.8% | -297.6% | -361.8% | -1,137.9% | -461.7% | -763.1% | - | -31.3% | -123.6% | -133.4% | -169.2% |
| ROCE % | - | -61.3% | -98.9% | -297.9% | -363.0% | -1,140.7% | -352.2% | 2,216.7% | - | -47.9% | -67.3% | -69.4% | -84.0% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for VANI
Vivani Medical (VANI) to Announce Earnings on Wednesday - MarketBeat
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxPcjl4bjRXN2ZvX0pJaVp3Qnl3cWZwaE1rUkhMS3lNYUQweUp1SzVDeFFudzhSdWYxSG90eVplYVAtT0ZNMTBpcWZjLXliTkNDTkJKTkRwb1hQTlo5QTkzTzVaNGZ3QVlhN3ZEQWxDZkk0ZV9ySVlTbGQ1Wmh2MldweS0tV2ZBQkV0SG0zdE…
Vivani Medical (NASDAQ: VANI) grants COO options and performance RSUs - Stock Titan
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxQa0pXTGFNOWZZcUF3ZlZqVHd0QXV4UXNyUnBXa1UwV0NrNTF4MkI1NzNjeFlSeW1KSVlHSDdWdHRxeXlJQXJCYWVwZERuWVdMQi1JRS0tZ2dEUE53ekt6LW9fQXdzbW5hUVc1a2kyRW1TRDNLQzkySVFMVjRuc2FmVU1STm5INHZUQkJpN0…
Vivani Medical (VANI) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxPanplVnRHNFJlZzFCcmRsOGJrb2xUOG1HMkJnUEJFcjExMlRyYmU3Znh6NkctbjZaUVBkeHZvb3Q1dkw0RWlHZWpiRk1CYTl2NWdQcHJZUGVCZkp0UnVzNi1NR0oxSjA0elBULXlSaFF1VjFmQkxSV0Vmcy1tV0xSbVVMdG5EZ3kxYXIteD…
Vivani Medical, Inc. Revenue Breakdown – NASDAQ:VANI - TradingView
<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE9FOFpYQ2Y0LVRVM3RMb2ZWSHZsM2tKRDdsUTJVckhoMWZtelZmTFFKR0p4UE16bS1UWTVCWUJvd2lXR3JlN2Q1VW53TzFsX3RSNzRJNDV5ejBKVkJWN0VpVElRWjVTaG9QNHllNzlRSkpJQjNvWEdR?oc=5" target="_blank">Vivani …
VIVANI MEDICAL ($VANI) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxOZDBJamhqLTdpaFNyejVPRXJudUhaS3pmb3pRcjlrMTJmVnB3OElEWWc5eDNoZjg4MmJfYUFUTXhWcVBQcU1tYk5vcTdrZzlLbVpzY2VyTXFZSDVCZGI4U05IeW1PUWZ1RWlMOEdJN2tOTWxENlN3NHkza0M2UUdLWU9aTGsxVkRCQ21QNF…
Indian sports wrap, August 5: Vani shares lead with Ayesha, Riya in WPGT - Sportstar
<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxPbHFTeVNwQ3ptNFJobUdRWF9lTFZ2ZDg3UGZGbENWWFFmZjRVSHh4eXNJMjVjdFBRMzdHT0s5SHpwSS1fOVk4S29abHcyRmtrcFNZYXFaa3lOMTNTQlZvQ3FfSVNGTWtPdi1KTThfbV9IbWdCR29vWUFhUGZRalpvWDUtdVVWNjNscjJoVF…
VANI — Frequently Asked Questions
What is the current share price of VANI?
As of 2026-08-05 17:25 PDT, VANI trades at $1.38 on NASDAQ/NYSE. Its 52-week range is $0.94 to $1.87.
What is the market capitalisation of VANI?
VANI has a market capitalisation of $105.47M on NASDAQ/NYSE.
What is the P/E ratio of VANI?
VANI trades at a trailing price-to-earnings (P/E) ratio of -3.21. Its price-to-book (P/B) ratio is 6.71.
Is VANI a good stock to buy?
This page provides a data-driven analysis of VANI, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.